PUBLIC CONTRACT · 2018
181000509 - Cisplatina sol inj pronta 50 mg frs/AMP e cisplatina sol in
- Contract value
- €1,249.60
- Signed on
- 26 February 2018
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 5091605PUBLISHED DESCRIPTION
181000509
Parties involved
- Place of performance
- Portugal, Lisboa, Lisboa
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- TEVA PHARMA - PROD. FARMACÊUTICOS · Tax ID 507045491
Values and timeline
- Contract price
- €1,249.60
- Procedure base price
- €1,249.60
- Total effective price
- Not reported on Portal BASE
- Publication date
- 3 January 2019
- Award date
- 22 February 2018
- Signing date
- 26 February 2018
- Performance period
- 1 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Preço ou custo
- CPV code
- 33690000-3 - Medicamentos vários
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2015/6 - Acordo quadro para o fornecimento de Medicamentos do Foro Oncológico
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 3756832
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.